Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Peritoneal Neoplasms 2Testicular Neoplasms 1Seminoma 1Ovarian Neoplasms 1Necrosis 1Medulloblastoma 1Hepatoblastoma 1Hearing Loss 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Platinum 2Magnetic Resonance Spectroscopy 2sodium thiosulfate 1Specimen Handling 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1Hearing 1Etoposide 1Cisplatin 1CTLA-4 Antigen 1Bleomycin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Seminoma × sodium thiosulfate × 90 days × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡